Kavar Capital Partners Group’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200	Closed	-$6K	–	338
2019 Q2	$6K	Buy	+200	New	+$6K	﹤0.01%	411
2018 Q3	–	Sell	-200	Closed	-$7K	–	284
2018 Q2	$7K	Hold	200	–	–	﹤0.01%	346
2018 Q1	$6K	Buy	+200	New	+$6K	﹤0.01%	359